ClinicalTrials.Veeva

Menu

Diagnosis and Treatment Strategy of Recurrent Spontaneous Abortion Associated With Thrombophilla

S

Shanghai First Maternity and Infant Hospital

Status and phase

Unknown
Phase 4

Conditions

Thrombophilia With Recurrent Pregnancy Loss

Treatments

Drug: Heparin
Drug: Aspirin

Study type

Interventional

Funder types

Other

Identifiers

NCT02986594
ShanghaiFIMH-0002

Details and patient eligibility

About

In this clinical cohort study, the investigators observe the efficacy of low molecular weight heparin in the treatment of thrombophilia with recurrent pregnancy loss with a prospective randomized controlled trial.

Enrollment

600 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Woman who had their Second miscarriage before 12(th) week of gestation.The patient who is diagnosed as thrombophilia with recurrent pregnancy loss. Signed consent form.

Exclusion criteria

  1. having experiencedsevere allergies, trauma history and/or operation history within 3 months
  2. with a history of mental illness and/or family history of mental illness
  3. limb disabled
  4. taking medicine within one month
  5. suffering major events or having mood swings
  6. with a history of recurrent pregnancy loss
  7. having internal and surgical disease(after having variety of physical examination such as electrocardiogram/hepatic and renal function/blood routine and urine rotine)
  8. Chromosome aberrations in anyone of the couple.
  9. patients who have drug contraindications

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

600 participants in 3 patient groups

aspirin group
Experimental group
Description:
low dose aspirin, 75-100mg, bid, after pregnancy
Treatment:
Drug: Aspirin
low molecular weight heparin group
Experimental group
Description:
low molecular weight heparin, 4100u, qd, after pregnancy
Treatment:
Drug: Heparin
combination group
Experimental group
Description:
low molecular weight heparin, 4100u, once a day and low dose aspirin, 75-100mg, bid. After pregnancy
Treatment:
Drug: Aspirin
Drug: Heparin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems